Act4Biosimilars is a global initiative aimed at increasing patient access to biologic medicines by helping to accelerate biosimilar approvability, accessibility, acceptability and affordability.
Act4Biosimilars is also on Twitter. Follow us at @Act4Biosimilars
Please see our community guidelines: bit.ly/3LZ8mmy
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.act4biosimilars.com
Act4biosimilars Questions
Act4Biosimilars's website is http://www.act4biosimilars.com
Act4Biosimilars's LinkedIn profile is https://www.linkedin.com/company/act4biosimilars
Act4Biosimilars has
1 employees.
View email and phone details for 1
employees at Act4Biosimilars.
Act4Biosimilars's industry is
Pharmaceutical Manufacturing
Act4Biosimilars's top competitors are
Sandoz Egypt,
American Leadership,
Sandoz,
レバテック株式会社,
Biosimilars Forum,
The Center For Biosimilars,
Solopharm,
Aircover Communications,
Igba - International Generic And Biosimilar Medicines Association,
Biosimilars Council.
Act4Biosimilars's categories are Pharmaceutical Manufacturing
Act4Biosimilars's founding year is 2022
